Effects of Acute Hepatic and Renal Failure on Pharmacokinetics of Flunixin Meglumine in Rats
スポンサーリンク
概要
- 論文の詳細を見る
The aim of this study was to investigate the effects of hepatic and renal failure on the pharmacokinetics of flunixin in carbon tetrachloride (CCl4)- and glycerol-treated rats. After intravenous administration of flunixin (2 mg/kg), the plasma concentration of flunixin was measured by high-performance liquid chromatography. Both acute hepatic and renal failure resulted in significantly increased area under the curve (AUC), prolonged elimination half-life (t1/2β), and reduced total body clearance (Cltot) compared with respective controls (P<0.05). In conclusion, hepatic failure as well as renal failure modified the pharmacokinetics of flunixin.
- 2011-04-01
著者
-
YUN Hyo-In
Institute of Veterinary Science, Lab of Veterinary Pharmacology and Toxicology, College of Veterinar
-
Hwang Youn-hwan
Institute Of Veterinary Science Chungnam National University
-
Yun Hyo-in
Institute Of Veterinary Science Chungnam National University
関連論文
- Pharmacokinetics of Toltrazuril and Its Metabolites, Toltrazuril Sulfoxide and Toltrazuril Sulfone, after a Single Oral Administration to Pigs
- Effects of Acute Hepatic and Renal Failure on Pharmacokinetics of Flunixin Meglumine in Rats
- Effects of Acute Hepatic and Renal Failure on Pharmacokinetics of Flunixin Meglumine in Rats